{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:44:21Z","timestamp":1793681061077,"version":"4.5.1"},"reference-count":134,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["178355"],"award-info":[{"award-number":["178355"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["496452"],"award-info":[{"award-number":["496452"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["IT27497"],"award-info":[{"award-number":["IT27497"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["IT24847"],"award-info":[{"award-number":["IT24847"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.tins.2023.12.004","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T00:22:27Z","timestamp":1705796547000},"page":"195-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions"],"prefix":"10.1016","volume":"47","author":[{"given":"Vern","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Rurak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalina","family":"Salmaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2272-1138","authenticated-orcid":false,"given":"Argel","family":"Aguilar-Valles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2023.12.004_bb0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","article-title":"Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study","volume":"176","author":"Popova","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0015","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0020","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jama.292.3.338","article-title":"Antidepressants and the risk of suicidal behaviors","volume":"292","author":"Jick","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.tins.2023.12.004_bb0025","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jad.2020.09.007","article-title":"A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 - January 2019","volume":"277","author":"Marcantoni","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.tins.2023.12.004_bb0030","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0035","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1038\/s41380-021-01093-2","article-title":"Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability","volume":"26","author":"Bonaventura","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial","volume":"176","author":"Phillips","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jad.2023.02.151","article-title":"Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study","volume":"330","author":"Leal","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.tins.2023.12.004_bb0055","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/mp.2017.225","article-title":"Engaging homeostatic plasticity to treat depression","volume":"23","author":"Workman","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0065","article-title":"Ketamine: mechanisms and relevance to treatment of depression","author":"Kim","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.tins.2023.12.004_bb0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jnc.15652","article-title":"Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders","volume":"166","author":"Lewis","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2023.12.004_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172870","article-title":"A historical review of antidepressant effects of ketamine and its enantiomers","volume":"190","author":"Wei","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tins.2023.12.004_bb0080","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1038\/s41380-020-0685-9","article-title":"Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions","volume":"25","author":"Hare","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0085","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.tins.2023.12.004_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8078","article-title":"Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation","volume":"364","author":"Moda-Sava","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.tins.2023.12.004_bb0095","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/mp.2015.176","article-title":"Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine","volume":"21","author":"Carreno","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0100","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.aaa3245","article-title":"Brain computation. Selective information routing by ventral hippocampal CA1 projection neurons","volume":"348","author":"Ciocchi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.tins.2023.12.004_bb0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41467-022-27977-7","article-title":"Two opposing hippocampus to prefrontal cortex pathways for the control of approach and avoidance behaviour","volume":"13","author":"Sanchez-Bellot","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2023.12.004_bb0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature25509","article-title":"Ketamine blocks bursting in the lateral habenula to rapidly relieve depression","volume":"554","author":"Yang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.tins.2023.12.004_bb0115","article-title":"Ketamine rescues anhedonia by cell-type and input specific adaptations in the nucleus accumbens","author":"Lucantonio","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.tins.2023.12.004_bb0120","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41380-019-0615-x","article-title":"Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model","volume":"25","author":"Price","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41398-023-02451-0","article-title":"Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression","volume":"13","author":"Kopelman","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0130","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tins.2023.12.004_bb0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2016.11.017","article-title":"Molecular neurobiology of mTOR","volume":"341","author":"Switon","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2023.12.004_bb0145","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-03047-0","article-title":"Antidepressant actions of ketamine engage cell-specific translation via eIF4E","volume":"590","author":"Aguilar-Valles","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tins.2023.12.004_bb0150","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00213-016-4256-3","article-title":"Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner","volume":"233","author":"Holubova","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tins.2023.12.004_bb0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","article-title":"Mechanistic target of rapamycin-independent antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"83","author":"Yang","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0160","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011528","article-title":"Principles of translational control: an overview","volume":"4","author":"Hershey","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.tins.2023.12.004_bb0165","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cell.2009.01.042","article-title":"Regulation of translation initiation in eukaryotes: mechanisms and biological targets","volume":"136","author":"Sonenberg","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.tins.2023.12.004_bb0170","series-title":"The Oxford Handbook of Neuronal Protein Synthesis","article-title":"Translational control through the eIF4E binding proteins in the brain","author":"Aguilar-Valles","year":"2018"},{"key":"10.1016\/j.tins.2023.12.004_bb0175","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.pnpbp.2011.05.010","article-title":"The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder","volume":"35","author":"Jernigan","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0180","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41386-020-0644-9","article-title":"Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin","volume":"45","author":"Abdallah","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2023.12.004_bb0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2022.01.104","article-title":"mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression","volume":"303","author":"Averill","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.tins.2023.12.004_bb0190","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1126\/science.1187532","article-title":"mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs","volume":"328","author":"Dowling","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.tins.2023.12.004_bb0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jnc.15541","article-title":"Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer disease","volume":"166","author":"Ma","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2023.12.004_bb0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biopsych.2017.11.028","article-title":"Calcium\/calmodulin-dependent protein kinase II and eukaryotic elongation factor 2 kinase pathways mediate the antidepressant action of ketamine","volume":"84","author":"Adaikkan","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113935","article-title":"Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine","volume":"177","author":"Hashimoto","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tins.2023.12.004_bb0210","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.biopsych.2018.05.007","article-title":"AMPA receptor activation-independent antidepressant actions of ketamine metabolite (S)-norketamine","volume":"84","author":"Yang","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0215","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.biopsych.2017.10.020","article-title":"Common neurotransmission recruited in (R,S)-ketamine and (2R,6R)-hydroxynorketamine-induced sustained antidepressant-like effects","volume":"84","author":"Pham","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0220","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.biopsych.2016.12.020","article-title":"(R)-Ketamine shows greater potency and longer lasting antidepressant effects than its metabolite (2R,6R)-hydroxynorketamine","volume":"82","author":"Yang","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0225","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tins.2023.12.004_bb0230","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejphar.2012.11.023","article-title":"Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in alpha7 nicotinic acetylcholine receptors","volume":"698","author":"Moaddel","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tins.2023.12.004_bb0235","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1021\/acs.orglett.7b02177","article-title":"Synthesis and N-methyl-d-aspartate (NMDA) receptor activity of ketamine metabolites","volume":"19","author":"Morris","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.tins.2023.12.004_bb0240","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature22084","article-title":"Effects of a ketamine metabolite on synaptic NMDAR function","volume":"546","author":"Suzuki","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tins.2023.12.004_bb0245","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1038\/nature22085","article-title":"Zanos et al. reply","volume":"546","author":"Zanos","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tins.2023.12.004_bb0250","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ijnp\/pyx108","article-title":"Lack of antidepressant effects of (2R,6R)-hydroxynorketamine in a rat learned helplessness model: comparison with (R)-ketamine","volume":"21","author":"Shirayama","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.tins.2023.12.004_bb0255","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41386-018-0084-y","article-title":"(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice","volume":"43","author":"Yamaguchi","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2023.12.004_bb0260","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jpsychires.2019.08.005","article-title":"Ketamine metabolite pilot study in a suicidal depression trial","volume":"117","author":"Grunebaum","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.tins.2023.12.004_bb0265","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03581","article-title":"GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine","volume":"3","author":"Miller","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.tins.2023.12.004_bb0270","doi-asserted-by":"crossref","first-page":"8106","DOI":"10.1073\/pnas.1414728112","article-title":"Optogenetic stimulation of infralimbic PFC reproduces ketamine's rapid and sustained antidepressant actions","volume":"112","author":"Fuchikami","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2023.12.004_bb0275","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41467-018-08168-9","article-title":"Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects","volume":"10","author":"Hare","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2023.12.004_bb0280","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1038\/s41380-020-0796-3","article-title":"Cell-type specific modulation of NMDA receptors triggers antidepressant actions","volume":"26","author":"Pothula","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0285","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1038\/s41467-022-30386-5","article-title":"Ketamine activates adult-born immature granule neurons to rapidly alleviate depression-like behaviors in mice","volume":"13","author":"Rawat","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2023.12.004_bb0290","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41586-022-04912-w","article-title":"Molecular landscapes of human hippocampal immature neurons across lifespan","volume":"607","author":"Zhou","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tins.2023.12.004_bb0295","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neuron.2021.10.036","article-title":"Transcriptomic taxonomy and neurogenic trajectories of adult human, macaque, and pig hippocampal and entorhinal cells","volume":"110","author":"Franjic","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2023.12.004_bb0300","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.neuron.2022.05.001","article-title":"Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2","volume":"110","author":"Lopez","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2023.12.004_bb0305","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41593-022-01146-x","article-title":"Experimenters\u2019 sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor","volume":"25","author":"Georgiou","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2023.12.004_bb0310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuropharm.2015.07.028","article-title":"Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: direct inhibition and disinhibition","volume":"100","author":"Miller","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tins.2023.12.004_bb0315","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2016.06.033","article-title":"GABAergic interneurons in the neocortex: from cellular properties to circuits","volume":"91","author":"Tremblay","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2023.12.004_bb0320","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1152\/physrev.00007.2017","article-title":"Hippocampal GABAergic inhibitory interneurons","volume":"97","author":"Pelkey","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tins.2023.12.004_bb0325","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature12983","article-title":"Interneuron cell types are fit to function","volume":"505","author":"Kepecs","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tins.2023.12.004_bb0330","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neubiorev.2020.11.002","article-title":"Hippocampal GABAergic interneurons and their co-localized neuropeptides in stress vulnerability and resilience","volume":"122","author":"Albrecht","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tins.2023.12.004_bb0335","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1113\/jphysiol.2004.073353","article-title":"Anatomical, physiological and molecular properties of Martinotti cells in the somatosensory cortex of the juvenile rat","volume":"561","author":"Wang","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.tins.2023.12.004_bb0340","doi-asserted-by":"crossref","DOI":"10.1126\/science.1255263","article-title":"Interneurons. Fast-spiking, parvalbumin(+) GABAergic interneurons: from cellular design to microcircuit function","volume":"345","author":"Hu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.tins.2023.12.004_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cobeha.2016.09.012","article-title":"Prefrontal cortex GABAergic deficits and circuit dysfunction in the pathophysiology and treatment of chronic stress and depression","volume":"14","author":"Ghosal","year":"2017","journal-title":"Curr. Opin. Behav. Sci."},{"key":"10.1016\/j.tins.2023.12.004_bb0350","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41398-018-0321-5","article-title":"Ketamine and selective activation of parvalbumin interneurons inhibit stress-induced dendritic spine elimination","volume":"8","author":"Ng","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0355","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI130808","article-title":"GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions","volume":"130","author":"Gerhard","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tins.2023.12.004_bb0360","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41467-019-13809-8","article-title":"Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines","volume":"11","author":"Ali","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2023.12.004_bb0365","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41593-022-01203-5","article-title":"Ketamine triggers a switch in excitatory neuronal activity across neocortex","volume":"26","author":"Cichon","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2023.12.004_bb0370","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41380-018-0341-9","article-title":"NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity","volume":"24","author":"Picard","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0375","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1038\/s41380-020-00916-y","article-title":"Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses","volume":"26","author":"Fogaca","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0380","article-title":"Altered GABAergic inhibition in CA1 pyramidal neurons modifies despair-like behavior in mice","author":"Yoon","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.tins.2023.12.004_bb0385","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.tins.2020.11.008","article-title":"A dendrite-focused framework for understanding the actions of ketamine and psychedelics","volume":"44","author":"Savalia","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tins.2023.12.004_bb0390","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/mp.2017.159","article-title":"Selective activation of parvalbumin interneurons prevents stress-induced synapse loss and perceptual defects","volume":"23","author":"Chen","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0395","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/mp.2016.188","article-title":"Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state","volume":"22","author":"Fuchs","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0400","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1523\/JNEUROSCI.2670-14.2015","article-title":"Depression of excitatory synapses onto parvalbumin interneurons in the medial prefrontal cortex in susceptibility to stress","volume":"35","author":"Perova","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2023.12.004_bb0405","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neubiorev.2021.05.003","article-title":"The anterior cingulate cortex as a key locus of ketamine's antidepressant action","volume":"127","author":"Alexander","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tins.2023.12.004_bb0410","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41386-020-0663-6","article-title":"Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression","volume":"45","author":"Farmer","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2023.12.004_bb0415","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41380-018-0028-2","article-title":"Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects","volume":"24","author":"Nugent","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0420","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/s41598-017-02062-y","article-title":"Myelination of the brain in major depressive disorder: an in vivo quantitative magnetic resonance imaging study","volume":"7","author":"Sacchet","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2023.12.004_bb0425","article-title":"Chronic unpredictable stress reduces immunostaining for connexins 43 and 30 and myelin basic protein in the rat prelimbic and orbitofrontal cortices","volume":"2","author":"Miguel-Hidalgo","year":"2018","journal-title":"Chronic Stress (Thousand Oaks)"},{"key":"10.1016\/j.tins.2023.12.004_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102790","article-title":"Aberrant levels of cortical myelin distinguish individuals with depressive disorders from healthy controls","volume":"32","author":"Baranger","year":"2021","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.tins.2023.12.004_bb0435","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41593-020-0621-y","article-title":"Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons","volume":"23","author":"Nagy","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2023.12.004_bb0440","article-title":"Myelin-associated oligodendrocytic basic protein-dependent myelin repair confers the long-lasting antidepressant effect of ketamine","author":"Huang","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0445","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nn945","article-title":"From neurobiology to treatment: progress against addiction","volume":"5","author":"Nestler","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2023.12.004_bb0450","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.biopsych.2008.06.008","article-title":"Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors","volume":"64","author":"Banasr","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0455","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbr.2014.07.019","article-title":"Antidepressant-like effect of the mGluR5 antagonist MTEP in an astroglial degeneration model of depression","volume":"273","author":"Domin","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.tins.2023.12.004_bb0460","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/npp.2011.319","article-title":"Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats","volume":"37","author":"Sun","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2023.12.004_bb0465","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41386-019-0471-z","article-title":"Evidence of decreased gap junction coupling between astrocytes and oligodendrocytes in the anterior cingulate cortex of depressed suicides","volume":"44","author":"Tanti","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2023.12.004_bb0470","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/glia.23994","article-title":"Implication of cerebral astrocytes in major depression: a review of fine neuroanatomical evidence in humans","volume":"69","author":"O'Leary","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.tins.2023.12.004_bb0475","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41386-018-0105-x","article-title":"Profiling changes in cortical astroglial cells following chronic stress","volume":"43","author":"Simard","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2023.12.004_bb0480","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00213-015-4128-2","article-title":"Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression","volume":"233","author":"Liu","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tins.2023.12.004_bb0485","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbrc.2022.03.068","article-title":"Rapid and sustained restoration of astrocytic functions by ketamine in depression model mice","volume":"616","author":"Ma","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tins.2023.12.004_bb0490","article-title":"Rapid and long-lasting antidepressant-like effects of ketamine and their relationship with the expression of brain enzymes, BDNF, and astrocytes","volume":"54","author":"Viana","year":"2020","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.tins.2023.12.004_bb0495","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-3-030-77375-5_14","article-title":"Ketamine action on astrocytes provides new insights into rapid antidepressant mechanisms","volume":"26","author":"Stenovec","year":"2021","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.tins.2023.12.004_bb0500","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3389\/fncel.2019.00240","article-title":"Ketamine within clinically effective range inhibits glutamate transmission from astrocytes to neurons and disrupts synchronization of astrocytic SICs","volume":"13","author":"Zhang","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tins.2023.12.004_bb0505","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/jnc.13715","article-title":"Subanesthetic doses of ketamine stabilize the fusion pore in a narrow flickering state in astrocytes","volume":"138","author":"Lasic","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2023.12.004_bb0510","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1007\/s12035-015-9562-y","article-title":"Ketamine inhibits ATP-evoked exocytotic release of brain-derived neurotrophic factor from vesicles in cultured rat astrocytes","volume":"53","author":"Stenovec","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tins.2023.12.004_bb0515","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/s41380-018-0083-8","article-title":"NMDAR-independent, cAMP-dependent antidepressant actions of ketamine","volume":"24","author":"Wray","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0520","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41380-021-01377-7","article-title":"Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine","volume":"27","author":"Yao","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0525","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41398-020-0733-x","article-title":"Essential role of microglial transforming growth factor-beta1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-beta1","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0530","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/bph.12974","article-title":"Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat","volume":"172","author":"Lilius","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tins.2023.12.004_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112631","article-title":"Ketamine\u2019s dose related multiple mechanisms of actions: Dissociative anesthetic to rapid antidepressant","volume":"390","author":"Lavender","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.tins.2023.12.004_bb0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157021","article-title":"Pharmacological investigations of the dissociative \u2018legal highs\u2019 diphenidine, methoxphenidine and analogues","volume":"11","author":"Wallach","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2023.12.004_bb0545","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1523\/JNEUROSCI.1316-22.2022","article-title":"NMDA receptor activation-dependent antidepressant-relevant behavioral and synaptic actions of ketamine","volume":"43","author":"Zanos","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2023.12.004_bb0550","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0773.1995.tb01041.x","article-title":"Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors","volume":"77","author":"Hustveit","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.tins.2023.12.004_bb0555","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00000542-199901000-00023","article-title":"Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells","volume":"90","author":"Hirota","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.tins.2023.12.004_bb0560","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0024-3205(80)90285-4","article-title":"The interaction of ketamine with the opiate receptor","volume":"26","author":"Smith","year":"1980","journal-title":"Life Sci."},{"key":"10.1016\/j.tins.2023.12.004_bb0565","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1073\/pnas.1916570117","article-title":"Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents","volume":"117","author":"Klein","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2023.12.004_bb0570","doi-asserted-by":"crossref","first-page":"9156","DOI":"10.1021\/jm4012214","article-title":"Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu\/kappa opioid receptor dual selectivity","volume":"56","author":"Yuan","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tins.2023.12.004_bb0575","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/s41380-019-0503-4","article-title":"Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism","volume":"24","author":"Williams","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0580","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of antidepressant effects of ketamine by opioid receptor antagonism","volume":"175","author":"Williams","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0585","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s00213-022-06118-4","article-title":"Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors","volume":"239","author":"Wulf","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tins.2023.12.004_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173228","article-title":"Opioid receptor system contributes to the acute and sustained antidepressant-like effects, but not the hyperactivity motor effects of ketamine in mice","volume":"208","author":"Zhang","year":"2021","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tins.2023.12.004_bb0595","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jamapsychiatry.2018.3990","article-title":"Association of combined naltrexone and ketamine with depressive symptoms in a case series of patients with depression and alcohol use disorder","volume":"76","author":"Yoon","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0600","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1176\/appi.ajp.2009.08060852","article-title":"A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence","volume":"167","author":"Pettinati","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0605","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/JCP.0000000000000287","article-title":"A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occurring alcohol dependence and major depression","volume":"35","author":"Adamson","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.tins.2023.12.004_bb0610","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","article-title":"Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268","volume":"117","author":"Lorrain","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2023.12.004_bb0615","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1073\/pnas.1819540116","article-title":"(2R,6R)-hydroxynorketamine exerts mGlu(2) receptor-dependent antidepressant actions","volume":"116","author":"Zanos","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2023.12.004_bb0620","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant drugs act by directly binding to TRKB neurotrophin receptors","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.tins.2023.12.004_bb0625","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fpsyt.2018.00726","article-title":"Microglia express mu opioid receptor: insights from transcriptomics and fluorescent reporter mice","volume":"9","author":"Maduna","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.tins.2023.12.004_bb0630","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/jnr.21653","article-title":"Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia","volume":"86","author":"Turchan-Cholewo","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.tins.2023.12.004_bb0635","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fimmu.2020.00300","article-title":"Opioid receptors in immune and glial cells-implications for pain control","volume":"11","author":"Machelska","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tins.2023.12.004_bb0640","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/1073858406294270","article-title":"NMDA Receptors in glia","volume":"13","author":"Verkhratsky","year":"2007","journal-title":"Neuroscientist"},{"key":"10.1016\/j.tins.2023.12.004_bb0645","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2016.06.029","article-title":"Opioid-induced hyperalgesia: cellular and molecular mechanisms","volume":"338","author":"Roeckel","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2023.12.004_bb0650","article-title":"The dark side of opioids in pain management: basic science explains clinical observation","volume":"1","author":"Rivat","year":"2016","journal-title":"Pain Rep."},{"key":"10.1016\/j.tins.2023.12.004_bb0655","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13578-020-00387-2","article-title":"Dynorphin activation of kappa opioid receptor promotes microglial polarization toward M2 phenotype via TLR4\/NF-kappaB pathway","volume":"10","author":"Liu","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.tins.2023.12.004_bb0660","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1073\/pnas.93.15.8051","article-title":"kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression","volume":"93","author":"Chao","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2023.12.004_bb0665","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ijnp\/pyab082","article-title":"Sex differences in the behavioral, molecular, and structural effects of ketamine treatment in depression","volume":"25","author":"Ponton","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.tins.2023.12.004_bb0670","doi-asserted-by":"crossref","DOI":"10.1177\/23982128221081645","article-title":"A systematic review of studies investigating the acute effects of N-methyl-D-aspartate receptor antagonists on behavioural despair in normal animals suggests poor predictive validity","volume":"6","author":"Viktorov","year":"2022","journal-title":"Brain Neurosci. Adv."}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223623002916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223623002916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:10:28Z","timestamp":1777497028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223623002916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":134,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0166223623002916"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2023.12.004","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}